Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
5,821,186
-
Share change
-
+300,114
-
Total reported value
-
$386,186,234
-
Price per share
-
$66.32
-
Number of holders
-
141
-
Value change
-
+$20,443,628
-
Number of buys
-
66
-
Number of sells
-
47
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2024
As of 30 Jun 2024,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,821,186 shares.
The largest 10 holders included
Fisher Asset Management, LLC, McElhenny Sheffield Capital Management, LLC, MORGAN STANLEY, Aptus Capital Advisors, LLC, Rockport Wealth LLC, BANK OF AMERICA CORP /DE/, BROWN ADVISORY INC, Royal Bank of Canada, LPL Financial LLC, and WELLS FARGO & COMPANY/MN.
This page lists
143
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.